BVF INC/IL - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.

Quarter-by-quarter ownership
BVF INC/IL ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$181,649,246
+55.6%
4,004,613
+40.7%
4.90%
+50.5%
Q2 2023$116,771,995
+27.6%
2,846,015
+11.1%
3.26%
-2.7%
Q1 2023$91,521,598
+116.0%
2,560,761
+128.3%
3.35%
+87.1%
Q4 2022$42,370,726
-66.7%
1,121,809
-61.0%
1.79%
-65.9%
Q3 2022$127,071,000
+168.9%
2,872,953
+125.1%
5.25%
+130.0%
Q2 2022$47,259,000
-23.0%
1,276,574
-6.4%
2.28%
-0.8%
Q1 2021$61,346,000
-20.5%
1,364,4610.0%2.30%
-24.2%
Q4 2020$77,147,000
+121.2%
1,364,461
+85.6%
3.04%
+59.7%
Q3 2020$34,878,000
-58.4%
735,055
-48.3%
1.90%
-63.3%
Q2 2020$83,891,000
-8.8%
1,422,842
-26.8%
5.17%
-39.6%
Q1 2020$91,937,000
-30.2%
1,944,517
-10.8%
8.57%
-14.2%
Q4 2019$131,678,000
+134.9%
2,179,735
+133.0%
9.98%
+69.5%
Q3 2019$56,049,000
+10933.3%
935,548
+9853.7%
5.89%
+8822.7%
Q4 2018$508,000
-98.1%
9,399
-98.2%
0.07%
-97.2%
Q3 2018$26,822,000
+12.9%
520,000
-8.8%
2.36%
+1.7%
Q2 2018$23,752,000
+20.0%
570,000
-32.9%
2.32%
-45.0%
Q2 2016$19,797,000850,0004.22%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders